Eulav Asset Management Bio Rad Laboratories, Inc. Transaction History

Eulav Asset Management

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$524.57 - $735.42 $2,622 - $3,677	-5 Reduced 0.04%	13,600 $7.66 Million
Q4 2021 Feb 11, 2022	SELL	$708.84 - $794.68 $1,417 - $1,589	-2 Reduced 0.01%	13,605 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $657 - $825	-1 Reduced 0.01%	13,607 $10.2 Million
Q2 2021 Aug 06, 2021	SELL	$576.64 - $649.04 $1,153 - $1,298	-2 Reduced 0.01%	13,608 $8.77 Million
Q1 2021 Apr 30, 2021	SELL	$547.01 - $662.35 $4,923 - $5,961	-9 Reduced 0.07%	13,610 $7.77 Million
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $9,702 - $12,225	19 Added 0.14%	13,619 $7.94 Million
Q3 2020 Nov 05, 2020	SELL	$454.43 - $535.6 $2,726 - $3,213	-6 Reduced 0.04%	13,600 $7.01 Million
Q2 2020 Aug 11, 2020	SELL	$334.87 - $493.06 $669 - $986	-2 Reduced 0.01%	13,606 $6.14 Million
Q1 2020 Apr 27, 2020	BUY	$320.01 - $409.07 $2,560 - $3,272	8 Added 0.06%	13,608 $4.77 Million
Q3 2019 Nov 12, 2019	BUY	$304.55 - $345.24 $517,735 - $586,908	1,700 Added 14.29%	13,600 $4.53 Million
Q2 2019 Aug 05, 2019	BUY	$286.93 - $312.59 $1.58 Million - $1.72 Million	5,500 Added 85.94%	11,900 $3.72 Million
Q1 2019 May 13, 2019	BUY	$224.3 - $317.41 $1.44 Million - $2.03 Million	6,400 New	6,400 $1.97 Million
Q3 2018 Oct 26, 2018	SELL	$289.28 - $326.15 $1.27 Million - $1.44 Million	-4,400 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	4,400	4,400 $996,000

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.48B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.